UBS AM’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.5M | Buy |
391,789
+336,462
| +608% | +$38.2M | 0.01% | 734 |
|
|
2025
Q1 | $5.82M | Buy |
55,327
+4,926
| +10% | +$518K | ﹤0.01% | 1495 |
|
|
2024
Q4 | $5.4M | Buy |
50,401
+10,563
| +27% | +$1.13M | ﹤0.01% | 1565 |
|
|
2024
Q3 | $3.99M | Sell |
39,838
-6,031
| -13% | -$604K | ﹤0.01% | 1692 |
|
|
2024
Q2 | $3.86M | Buy |
45,869
+30,130
| +191% | +$2.54M | ﹤0.01% | 1636 |
|
|
2024
Q1 | $1.15M | Hold |
15,739
| – | – | ﹤0.01% | 1937 |
|
|
2023
Q4 | $1.12M | Hold |
15,739
| – | – | ﹤0.01% | 1963 |
|
|
2023
Q3 | $943K | Sell |
15,739
-2,912
| -16% | -$174K | ﹤0.01% | 1988 |
|
|
2023
Q2 | $1.37M | Hold |
18,651
| – | – | ﹤0.01% | 1857 |
|
|
2023
Q1 | $1.37M | Buy |
18,651
+1,030
| +6% | +$75.8K | ﹤0.01% | 1857 |
|
|
2022
Q4 | $1.18M | Sell |
17,621
-10,625
| -38% | -$710K | ﹤0.01% | 1777 |
|
|
2022
Q3 | $1.52M | Hold |
28,246
| – | – | ﹤0.01% | 1739 |
|
|
2022
Q2 | $1.57M | Sell |
28,246
-6,619
| -19% | -$368K | ﹤0.01% | 1727 |
|
|
2022
Q1 | $2.45M | Buy |
34,865
+2,015
| +6% | +$141K | ﹤0.01% | 1698 |
|
|
2021
Q4 | $3.17M | Sell |
32,850
-1,552
| -5% | -$150K | ﹤0.01% | 1639 |
|
|
2021
Q3 | $2.99M | Sell |
34,402
-864
| -2% | -$75.1K | ﹤0.01% | 1642 |
|
|
2021
Q2 | $2.89M | Buy |
35,266
+6,441
| +22% | +$527K | ﹤0.01% | 1683 |
|
|
2021
Q1 | $2.74M | Buy |
28,825
+882
| +3% | +$83.9K | ﹤0.01% | 1624 |
|
|
2020
Q4 | $1.73M | Sell |
27,943
-113,225
| -80% | -$7.02M | ﹤0.01% | 1741 |
|
|
2020
Q3 | $8.39M | Buy |
141,168
+111,105
| +370% | +$6.61M | ﹤0.01% | 985 |
|
|
2020
Q2 | $2.1M | Buy |
30,063
+13
| +0% | +$907 | ﹤0.01% | 1503 |
|
|
2020
Q1 | $1.36M | Sell |
30,050
-83,585
| -74% | -$3.79M | ﹤0.01% | 1577 |
|
|
2019
Q4 | $7.39M | Sell |
113,635
-5,529
| -5% | -$360K | ﹤0.01% | 1055 |
|
|
2019
Q3 | $7.4M | Buy |
119,164
+608
| +0.5% | +$37.8K | 0.01% | 1060 |
|
|
2019
Q2 | $8.44M | Sell |
118,556
-1,796
| -1% | -$128K | 0.01% | 1007 |
|
|
2019
Q1 | $9.44M | Buy |
120,352
+2,395
| +2% | +$188K | 0.01% | 949 |
|
|
2018
Q4 | $9.99M | Sell |
117,957
-7,156
| -6% | -$606K | 0.01% | 875 |
|
|
2018
Q3 | $21.4M | Sell |
125,113
-43,834
| -26% | -$7.51M | 0.02% | 737 |
|
|
2018
Q2 | $21.8M | Sell |
168,947
-11,599
| -6% | -$1.5M | 0.02% | 746 |
|
|
2018
Q1 | $18.6M | Sell |
180,546
-3,001
| -2% | -$309K | 0.01% | 776 |
|
|
2017
Q4 | $15.7M | Buy |
183,547
+53
| +0% | +$4.53K | 0.01% | 803 |
|
|
2017
Q3 | $15.6M | Sell |
183,494
-1,489
| -0.8% | -$126K | 0.01% | 794 |
|
|
2017
Q2 | $14M | Sell |
184,983
-12,912
| -7% | -$978K | 0.01% | 834 |
|
|
2017
Q1 | $13.1M | Sell |
197,895
-8,200
| -4% | -$541K | 0.01% | 840 |
|
|
2016
Q4 | $13.1M | Sell |
206,095
-13,729
| -6% | -$870K | 0.01% | 804 |
|
|
2016
Q3 | $14M | Sell |
219,824
-4,937
| -2% | -$314K | 0.02% | 802 |
|
|
2016
Q2 | $16.7M | Buy |
224,761
+71,306
| +46% | +$5.31M | 0.02% | 745 |
|
|
2016
Q1 | $10.3M | Sell |
153,455
-11,308
| -7% | -$755K | 0.01% | 841 |
|
|
2015
Q4 | $11.1M | Sell |
164,763
-4,626
| -3% | -$313K | 0.01% | 836 |
|
|
2015
Q3 | $9.05M | Buy |
169,389
+24,428
| +17% | +$1.31M | 0.01% | 891 |
|
|
2015
Q2 | $9.12M | Buy |
144,961
+122,740
| +552% | +$7.73M | 0.01% | 915 |
|
|
2015
Q1 | $1.07M | Buy |
22,221
+242
| +1% | +$11.6K | ﹤0.01% | 1606 |
|
|
2014
Q4 | $729K | Buy |
21,979
+1,166
| +6% | +$38.7K | ﹤0.01% | 1738 |
|
|
2014
Q3 | $610K | Buy |
20,813
+2,492
| +14% | +$73K | ﹤0.01% | 1764 |
|
|
2014
Q2 | $712K | Sell |
18,321
-6,489
| -26% | -$252K | ﹤0.01% | 1717 |
|
|
2014
Q1 | $1.04M | Sell |
24,810
-1,061
| -4% | -$44.5K | ﹤0.01% | 1548 |
|
|
2013
Q4 | $849K | Sell |
25,871
-196,649
| -88% | -$6.45M | ﹤0.01% | 1579 |
|
|
2013
Q3 | $6.01M | Sell |
222,520
-1,616,799
| -88% | -$43.7M | 0.01% | 939 |
|
|
2013
Q2 | $42.9M | Buy |
+1,839,319
| New | +$42.9M | 0.06% | 353 |
|